company
as of 2026-07-01Heinrich-Heine University, Duesseldorf
at a glance
14 trials sponsored · 21 assets in the graph
Synthesized from structured facts only — each point cited above.
Financials
SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).
Pipeline
21 assets
AmisulprideOlanzapineRisperidone"pronia.ai" medical device for high risk psychosis prognosisCognitive Behavioral Therapy (CBT)IPPI (Integrated Preventive Psychological Intervention)Integrated Social Cognitive and Behavioral Skills TherapyN-acetylcysteineNeurocognitive Remediation TherapyPSM (Psychological stress management)Supportive Counselling (SC)Supportive managementTreatment-as-usual (TAU)antipsychotics vs. Lorazepam (Drugs)balance and tone programendurance trainingmaintained antipsychotic treatment vs. stepwise drug discontinuationnicotine nasal sprayrTMSrTMS, "repetitive transcranial magnetic stimulation"weight management program
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Amisulpride
drugsmall molecule
Olanzapine
drugsmall molecule
Risperidone
drugsmall molecule
Cognitive Behavioral Therapy (CBT)
drugBEHAVIORAL
drug
N-acetylcysteine
drugsmall molecule